All
D-VRd May Improve Minimal Residual Disease Responses in Multiple Myeloma
For patients with transplant-ineligible or -deferred newly diagnosed multiple myeloma, the addition of Darzalex to VRd improved MRD responses as well as progression-free survival.
Smoking May Be Linked With Genetic Mutations, Progression Risk in MDS
Results from the study also showed the potential association between smoking, disease progression and survival in patients with myelodysplastic syndromes.
CAR-T Cell Therapy Shows EFS Benefit in Pediatric Leukemia Subset
Treatment with bicistronic CD19/CD22 CAR-T cell therapy has shown event-free survival improvements in children with relapsed or refractory B-ALL.
Blincyto With Chemo May Improve Disease-Free Survival in Pediatric B-ALL
Pediatric patients with standard-risk B-ALL demonstrated significantly improved disease-free survival with Blincyto plus chemotherapy versus chemotherapy alone.
CURE Honors Seven Honorees at MPN Heroes Event
CURE celebrated seven MPN Heroes, who ranged from patients to medical professionals, on the contributions they made in the community.
SBRT May Be Effective in Managing Intermediate-Risk Prostate Cancer
Treatment with five-fraction SBRT could be effective versus traditional radiation in certain patients with low- or intermediate-risk prostate cancer.
The ABCs of ADCs in Breast Cancer
Since 2000, antibody-drug conjugates have been approved by the Food and Drug Administration for various cancer types, such as breast cancer.
After Cancer, My Doctors Assume Everything I Have Is Cancer
When you’ve had cancer do doctors assume every ailment is cancer for you?
‘Rocky’ Series Star Dolph Lundgren is Cancer-Free, Boxer Israel Vazquez Died of Cancer and More
From a Hollywood star sharing an uplifting update to the death of a three-time boxing champion, here’s what’s happening in the cancer space this week.
MRIs May Predict Organ Preservation, Survival in Rectal Cancer
MRIs were able to predict organ preservation and survival with the “watch-and-wait” approach in patients with rectal cancer.
Lenvima Combo Misses End Goal in Children with Osteosarcoma
Combination therapy of Lenvima with Ipex and Vepesid misses end goal in children with osteosarcoma, but further research is needed.
Finding Hope With Antibody-Drug Conjugates in Managing Breast Cancer
With more than 150 treatments being studied in clinical trials, what is on the horizon for antibody-drug conjugates in breast cancer?
My Expectations of Follicular Lymphoma Treatment
When I started receiving treatment for follicular lymphoma, I wasn’t sure what to expect regarding treatment — and a lot of things were unexpected.
‘Too Young For Cancer’ Author on the Importance of Advocating for Yourself
Author and kidney cancer survivor Katie Coleman explains why patients with cancer need to advocate for themselves when navigating the medical system.
FDA Grants Fast Track Designation to R289 in Lower-Risk MDS
The novel treatment is being evaluated for patients with previously treated transfusion-dependent lower-risk myelodysplastic syndrome.
FDA OKs Imfinzi for Limited-Stage Small Cell Lung Cancer
Imfinzi was approved by the FDA for the treatment of adults with limited-stage small cell lung cancer without disease progression after chemotherapy and radiation.
FDA Approves Bizengri for Some with NSCLC, Pancreatic Adenocarcinoma
The FDA has approved the first systemic therapy for patients with NSCLC or pancreatic adenocarcinoma with an NRG1 gene fusion.
Expert Explains Lymphoma After Dave Coulier's Diagnosis
An expert from the CURE® advisory board explains the likely treatability of Dave Coulier’s non-Hodgkin lymphoma.
Time, My Most Precious Gift After Breast Cancer
I’ve learned to live in the present by avoiding clocks, a necessary change in my life after having breast cancer.
Partial Nephrectomy May Improve Survival in cT1a Renal Cell Carcinoma
Partial nephrectomy showed similar overall and cancer-specific survival rates to radiofrequency ablation in patients with cT1a RCC.
Phase 3 Study for Advanced Pancreatic Cancer Meets Survival Goal
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields versus chemotherapy.
FDA Grants Breakthrough Therapy Designation to Sac-TMT for Some with NSCLC
The FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for patients with advanced or metastatic nonsquamous NSCLC with EGFR mutations.
Nemvaleukin Shows Manageable Safety Profile in Advanced Solid Tumors
In patients with advanced solid tumors, treatment with nemvaleukin with or without Keytruda demonstrated antitumor activity and tolerability.
Loss and Life Have Given Me a Wealth of Gratitude After Cancer
When my grandmother passed away one Thanksgiving after my colon cancer diagnosis, I realized how grateful I am for her life and my own as a survivor.
How a Singer-Songwriter’s Cancer History Can Be Heard in Her Music
Singer-songwriter Danielia Cotton, a thyroid cancer survivor and marathon runner shared how her experiences impact her art.
Blenrep Combo Accepted for FDA Review in R/R Multiple Myeloma
The FDA has accepted a biologics license application for Blenrep plus bortezomib or pomalidomide for patients with relapsed or refractory multiple myeloma.
Tiragolumab Plus Tecentriq Misses Survival Endpoint for Lung Cancer Subset
The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some patients with non-small cell lung cancer.
‘The Future Is Bright’ for R/R CLL Treatment Landscape
Current treatments for patients with relapsed or refractory chronic lymphocytic leukemia have shown better outcomes than published data, an expert said.
My Gratitude for Brighter Moments as a New Mom With Cancer
Reflecting on my first diagnosis of breast cancer at 36 weeks pregnant has made me feel grateful for the positive moments during that dark time.
Oncology Drugs, Diagnostics Approved by the FDA in November 2024
The FDA approved several drugs throughout November for the treatment of diseases including leukemia and biliary tract cancer, in addition to a diagnostic for solid cancers.
